RIFADIN Side Effects

7022117-8 | Linear Iga Disease, Thrombocytopenia
on Sep 27, 2010 Male patient from FRANCE , 62 years of age, was diagnosed with osteitis, thrombosis prophylaxis and was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: linear iga disease, thrombocytopenia. Rifadin dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AVANDIA (View Avandia Review and Avandia Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ESIDRIX (View Esidrix Review and Esidrix Label ). Patient was hospitalized.

6987139-1 | Eosinophilia, Interstitial Lung Disease, Pulmonary Alveolar Haemorrhage
Patient was taking Rifadin (View Usage). Patient had the following side effects: eosinophilia, interstitial lung disease, pulmonary alveolar haemorrhage on Sep 13, 2010 from FRANCE Additional patient health information: Female patient , 80 years of age, . Rifadin dosage: . During the same period patient was treated with ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), INIPOMP (View Inipomp Review and Inipomp Label ), FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (View Fosinopril Sodium And Hydrochlorothiazide Review and Fosinopril Sodium And Hydrochlorothiazide Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), GLUCOR (View Glucor Review and Glucor Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TEMESTA (View Temesta Review and Temesta Label ).

6978336-X | Abdominal Pain, Blood Bilirubin Increased, Cytolytic Hepatitis, Nausea, Pancreatitis Acute, Rash Maculo-papular
Adverse event was reported on Sep 10, 2010 by a Female patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , 76 years of age, After Rifadin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood bilirubin increased, cytolytic hepatitis, nausea (What is nausea?), pancreatitis acute, rash maculo-papular. During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), ARAVA (View Arava Review and Arava Label ), LYRICA (View Lyrica Review and Lyrica Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), CALCIDOSE (View Calcidose Review and Calcidose Label ). Patient was hospitalized.

6970285-6 | Hepatitis Acute, Hepatorenal Failure, Jaundice
on Sep 07, 2010 Male patient from ITALY , 68 years of age, was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute, hepatorenal failure, jaundice (What is jaundice?). Rifadin dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CLEXANE (View Clexane Review and Clexane Label ), ESOPRAL (View Esopral Review and Esopral Label ). Patient was hospitalized.


6929758-4 | Hepatitis Acute, Hepatorenal Failure, Jaundice
on Aug 17, 2010 Male patient from ITALY , 68 years of age, was treated with Rifadin (View Usage). Patient had the following side effects: hepatitis acute, hepatorenal failure, jaundice (What is jaundice?). Rifadin dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CLEXANE (View Clexane Review and Clexane Label ), ESOPRAL (View Esopral Review and Esopral Label ). Patient was hospitalized.

6927763-5 | Hepatitis Acute
Patient was taking Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: hepatitis acute on Aug 16, 2010 from ITALY Additional patient health information: Male patient , 68 years of age, . Rifadin dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CLEXANE (View Clexane Review and Clexane Label ), ESOPRAL (View Esopral Review and Esopral Label ). Patient was hospitalized.

6918756-2 | Altered State Of Consciousness, Diarrhoea, Somnolence
Adverse event was reported on Aug 09, 2010 by a Male patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with lung infection and. Location: FRANCE , 43 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, diarrhoea, somnolence. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), ROCEPHIN (Dose:2 Unit(s)) (View Rocephin Review and Rocephin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6866303-6 | Bilirubin Conjugated Increased, Blood Bilirubin Increased, Eosinophilia, Pruritus, Pyrexia, Rash Maculo-papular
on Jul 20, 2010 Male patient from FRANCE , 77 years of age, was treated with Rifadin (View Usage). Patient had the following side effects: bilirubin conjugated increased, blood bilirubin increased, eosinophilia, pruritus, pyrexia, rash maculo-papular. Rifadin dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ). Patient was hospitalized.

6862167-5 | Cholestasis, Jaundice
on Jul 19, 2010 Male patient from FRANCE , 81 years of age, was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: cholestasis, jaundice (What is jaundice?). Rifadin dosage: Dose:6 Unit(s). During the same period patient was treated with FUCIDINE CAP (Dose:6 Unit(s)) (View Fucidine Cap Review and Fucidine Cap Label ). Patient was hospitalized.

6844311-9 | Altered State Of Consciousness, Malaise, Metabolic Acidosis, Pruritus, Rash, Renal Failure Acute, Shock, Vomiting
Patient was taking Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, malaise, metabolic acidosis, pruritus, rash (What is rash?), renal failure acute, shock, vomiting on Jul 12, 2010 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with postoperative wound infection and. Rifadin dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), IODOFORM (View Iodoform Review and Iodoform Label ), BETADINE ^PURDUE^ (View Betadine ^purdue^ Review and Betadine ^purdue^ Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMAREL (View Amarel Review and Amarel Label ), TAREG (Dose:1 Unit(s)) (View Tareg Review and Tareg Label ). Patient was hospitalized.

6812194-9 | Cholestasis
Adverse event was reported on Jun 28, 2010 by a Female patient taking Rifadin (View Usage) (Dosage: ) . Location: FRANCE , 69 years of age, Patient had the following side effects: cholestasis. During the same period patient was treated with OFLOCET (View Oflocet Review and Oflocet Label ), CIFLOX (View Ciflox Review and Ciflox Label ).

6779243-8 | Neutropenia
on Jun 17, 2010 Female patient from FRANCE , 74 years of age, was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: neutropenia. Rifadin dosage: . During the same period patient was treated with ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ). Patient was hospitalized.

6779211-6 | Cholestasis, Cytolytic Hepatitis, Nephritis Allergic
on Jun 15, 2010 Male patient from FRANCE , 45 years of age, was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis, nephritis allergic. Rifadin dosage: . During the same period patient was treated with IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), VANCOCIN HYDROCHLORIDE (View Vancocin Hydrochloride Review and Vancocin Hydrochloride Label ), LOVENOX (View Lovenox Review and Lovenox Label ), IMOVANE (Dose:1 Unit(s)) (View Imovane Review and Imovane Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6779192-5 | Pancytopenia, Thrombocytopenia
Patient was taking Rifadin (View Usage). Patient had the following side effects: pancytopenia, thrombocytopenia on Jun 15, 2010 from FRANCE Additional patient health information: Female patient , 80 years of age, . Rifadin dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6775493-5 | Altered State Of Consciousness, Diarrhoea, Somnolence
Adverse event was reported on Jun 15, 2010 by a Male patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with lung infection and. Location: FRANCE , 43 years of age, After Rifadin was administered, patient had the following side effects: altered state of consciousness, diarrhoea, somnolence. During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), ROCEPHIN (Dose:2 Unit(s)) (View Rocephin Review and Rocephin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6733573-4 | Pancreatitis Acute
on May 18, 2010 Female patient from FRANCE , 65 years of age, weighting 116.8 lb, was diagnosed with streptococcal infection (What is streptococcal infection?), crohn's disease (What is crohn's disease?) and was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Rifadin dosage: . During the same period patient was treated with IMUREL (Dose:2 Unit(s)) (View Imurel Review and Imurel Label ), REMICADE (View Remicade Review and Remicade Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

6703884-7 | Arthralgia
on Apr 27, 2010 Female patient from FRANCE , 53 years of age, was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?) and was treated with Rifadin (View Usage). Patient had the following side effects: arthralgia. Rifadin dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), PIRILENE (View Pirilene Review and Pirilene Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), ANTIVIRALS FOR SYSTEMIC USE (View Antivirals For Systemic Use Review and Antivirals For Systemic Use Label ). Patient was hospitalized.

6699936-0 | Abdominal Pain Upper, Lipase Increased, Pancreatitis Necrotising
Patient was taking Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: abdominal pain upper, lipase increased, pancreatitis necrotising on Apr 27, 2010 from FRANCE Additional patient health information: Male patient , 21 years of age, was diagnosed with lung infection, renal transplant and. Rifadin dosage: . During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), MYFORTIC (View Myfortic Review and Myfortic Label ), PROGRAFT (View Prograft Review and Prograft Label ), MOPRAL (View Mopral Review and Mopral Label ), AMLOR (View Amlor Review and Amlor Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ).

6695980-8 | Altered State Of Consciousness, Malaise, Metabolic Acidosis, Pruritus, Rash, Renal Failure Acute, Shock, Vomiting
Adverse event was reported on Apr 16, 2010 by a Male patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with postoperative wound infection and. Location: FRANCE , 79 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, malaise, metabolic acidosis, pruritus, rash (What is rash?), renal failure acute, shock, vomiting. During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), IODOFORM (View Iodoform Review and Iodoform Label ), BETADINE ^PURDUE^ (View Betadine ^purdue^ Review and Betadine ^purdue^ Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMAREL (View Amarel Review and Amarel Label ), TAREG (Dose:1 Unit(s)) (View Tareg Review and Tareg Label ). Patient was hospitalized.

6682494-4 | Dermatitis Exfoliative, Eosinophilia, Jaundice Cholestatic, Pancreatitis
on Apr 13, 2010 Male patient from FRANCE , 64 years of age, was treated with Rifadin (View Usage). Patient had the following side effects: dermatitis exfoliative, eosinophilia, jaundice cholestatic, pancreatitis. Rifadin dosage: . During the same period patient was treated with ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

6656212-X | Epistaxis, Hepatomegaly, Platelet Count Decreased, Purpura, Splenomegaly, Ventricular Tachycardia
on Mar 26, 2010 Female patient from UNITED STATES , weighting 190.7 lb, was diagnosed with endocarditis staphylococcal, thrombosis prophylaxis and was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: epistaxis, hepatomegaly, platelet count decreased, purpura, splenomegaly, ventricular tachycardia. Rifadin dosage: 300 Mg Daily Po. During the same period patient was treated with HEPARIN (5,000 Units Every 8 Hours Sq) (View Heparin Review and Heparin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), INSULIN (View Insulin Review and Insulin Label ), ISOSORBIDE MONOHYDRATE (View Isosorbide Monohydrate Review and Isosorbide Monohydrate Label ).

6627788-3 | Eosinophilia, Lymphopenia, Purpura, Rash Erythematous, Renal Failure Acute, Urticaria
Patient was taking Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, lymphopenia, purpura, rash erythematous, renal failure acute, urticaria on Mar 09, 2010 from FRANCE Additional patient health information: Male patient , 78 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Rifadin dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), LASILIX (View Lasilix Review and Lasilix Label ), PLAVIX (Dose:1 Unit(s)) (View Plavix Review and Plavix Label ), HYPERIUM (Dose:2 Unit(s)) (View Hyperium Review and Hyperium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PRAXILENE (Dose:2 Unit(s)) (View Praxilene Review and Praxilene Label ). Patient was hospitalized.

6601348-2 | C-reactive Protein Increased, Pyrexia
Adverse event was reported on Feb 23, 2010 by a Female patient taking Rifadin (View Usage) (Dosage: ) . Location: FRANCE , 72 years of age, Patient had the following side effects: c-reactive protein increased, pyrexia. During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ).

6599187-4 | Eosinophilia, Lymphopenia, Purpura, Rash Erythematous, Renal Failure Acute, Urticaria
on Feb 22, 2010 Male patient from FRANCE , 78 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: eosinophilia, lymphopenia, purpura, rash erythematous, renal failure acute, urticaria. Rifadin dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), LASILIX (View Lasilix Review and Lasilix Label ), PLAVIX (Dose:1 Unit(s)) (View Plavix Review and Plavix Label ), HYPERIUM (Dose:2 Unit(s)) (View Hyperium Review and Hyperium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PRAXILENE (Dose:2 Unit(s)) (View Praxilene Review and Praxilene Label ). Patient was hospitalized.

6584959-2 | Agranulocytosis, Cytolytic Hepatitis
on Feb 09, 2010 Female patient from FRANCE , 25 years of age, weighting 169.8 lb, was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, cytolytic hepatitis. Rifadin dosage: Dose:2 Unit(s). During the same period patient was treated with DALACIN (View Dalacin Review and Dalacin Label ). Patient was hospitalized.

6579233-4 | Cytolytic Hepatitis, Hepatitis Cholestatic, Mixed Liver Injury
Patient was taking Rifadin (View Usage). Patient had the following side effects: cytolytic hepatitis, hepatitis cholestatic, mixed liver injury on Feb 09, 2010 from FRANCE Additional patient health information: Female patient , 38 years of age, weighting 149.9 lb, was diagnosed with infection prophylaxis, colectomy, sedation and. Rifadin dosage: . During the same period patient was treated with CANCIDAS (View Cancidas Review and Cancidas Label ), RIMIFON (View Rimifon Review and Rimifon Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ). Patient was hospitalized.

6564726-6 | Dermatitis Exfoliative, Eosinophilia
Adverse event was reported on Jan 28, 2010 by a Male patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with septic shock and. Location: FRANCE , 64 years of age, After Rifadin was administered, patient had the following side effects: dermatitis exfoliative, eosinophilia. During the same period patient was treated with ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ). Patient was hospitalized.

6551516-3 | Cholestasis, Cytolytic Hepatitis
on Jan 22, 2010 Female patient from FRANCE , 14 years of age, was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis. Rifadin dosage: . During the same period patient was treated with TARDYFERON /GFR/ (View Tardyferon /gfr/ Review and Tardyferon /gfr/ Label ), ACTISKENAN (View Actiskenan Review and Actiskenan Label ), ATARAX (View Atarax Review and Atarax Label ), LOVENOX (View Lovenox Review and Lovenox Label ), DUPHALAC /NET/ (View Duphalac /net/ Review and Duphalac /net/ Label ), OFLOCET (View Oflocet Review and Oflocet Label ). Patient was hospitalized.

6539186-1 | Renal Failure
on Jan 11, 2010 Female patient from FRANCE , 92 years of age, was diagnosed with prophylaxis and was treated with Rifadin (View Usage). Patient had the following side effects: renal failure. Rifadin dosage: Dose:6 Unit(s). During the same period patient was treated with BACTRIM (Dose:3 Unit(s)) (View Bactrim Review and Bactrim Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), NICARDIPINE HCL (View Nicardipine Hcl Review and Nicardipine Hcl Label ), STILNOX (View Stilnox Review and Stilnox Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6537547-8 | Cholestasis, Cytolytic Hepatitis
Patient was taking Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: cholestasis, cytolytic hepatitis on Jan 12, 2010 from FRANCE Additional patient health information: Male patient , 67 years of age, was diagnosed with thrombosis prophylaxis and. Rifadin dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), SOLUPRED (View Solupred Review and Solupred Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), RAPAMUNE (View Rapamune Review and Rapamune Label ), SECTRAL (View Sectral Review and Sectral Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PREVISCAN (View Previscan Review and Previscan Label ).

6517728-X | Blister, Mouth Ulceration, Thrombocytopenia
Adverse event was reported on Dec 16, 2009 by a Male patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with endocarditis (What is endocarditis?) and. Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: blister, mouth ulceration, thrombocytopenia. During the same period patient was treated with CALCIPARINE (View Calciparine Review and Calciparine Label ), CIFLOX (View Ciflox Review and Ciflox Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), CRESTOR (View Crestor Review and Crestor Label ), AMLOR (View Amlor Review and Amlor Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), LANTUS (View Lantus Review and Lantus Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ). Patient was hospitalized.

6502899-1 | C-reactive Protein Increased, Inflammation, Leukocytosis, Pyrexia, Rash Maculo-papular, Transaminases Increased
on Dec 14, 2009 Female patient from FRANCE , 76 years of age, was treated with Rifadin (View Usage). Patient had the following side effects: c-reactive protein increased, inflammation, leukocytosis, pyrexia, rash maculo-papular, transaminases increased. Rifadin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), AMIKLIN (View Amiklin Review and Amiklin Label ), IMIPENEM AND CILASTATIN SODIUM (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CIFLOX (View Ciflox Review and Ciflox Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ARIXTRA (View Arixtra Review and Arixtra Label ), FLIXOTIDE ^GLAXO^ (View Flixotide ^glaxo^ Review and Flixotide ^glaxo^ Label ). Patient was hospitalized.

6479955-X | Asthenia, Cardiac Failure Congestive, Jaundice, Oedema Peripheral
on Nov 17, 2009 Male patient from FRANCE , 93 years of age, was diagnosed with infective spondylitis and was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: asthenia, cardiac failure congestive, jaundice (What is jaundice?), oedema peripheral. Rifadin dosage: . During the same period patient was treated with CLAMOXYL FOR INJECTION (View Clamoxyl For Injection Review and Clamoxyl For Injection Label ), APROVEL (View Aprovel Review and Aprovel Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASILIX (View Lasilix Review and Lasilix Label ), PLAVIX (View Plavix Review and Plavix Label ), TEMESTA (View Temesta Review and Temesta Label ), SKENAN (View Skenan Review and Skenan Label ). Patient was hospitalized.

6479829-4 | Angiopathy, Haemolytic Uraemic Syndrome, Thrombocytopenia
Patient was taking Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: angiopathy, haemolytic uraemic syndrome, thrombocytopenia on Dec 07, 2009 from FRANCE Additional patient health information: Female patient , weighting 19.84 lb, was diagnosed with cholangitis, biliary tract infection and. Rifadin dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), FORTUM /UNK/ (View Fortum /unk/ Review and Fortum /unk/ Label ), AMIKLIN (View Amiklin Review and Amiklin Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), FUMAFER (View Fumafer Review and Fumafer Label ), VEDROP (View Vedrop Review and Vedrop Label ), MOTILIUM (View Motilium Review and Motilium Label ). Patient was hospitalized.

6404043-8 | Arthralgia, Myalgia
Adverse event was reported on Oct 08, 2009 by a Female patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with pulmonary tuberculosis and. Location: , 66 years of age, Patient had the following side effects: arthralgia, myalgia. During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ADVAGRAF (TACROLIMUS) (View Advagraf (tacrolimus) Review and Advagraf (tacrolimus) Label ), IMUREL /00001501/ (View Imurel /00001501/ Review and Imurel /00001501/ Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6338189-X | Blood Amylase Increased, Lipase Increased, Pancreatitis
on Aug 26, 2009 Female patient from , 59 years of age, was diagnosed with endocarditis (What is endocarditis?), prophylaxis against gastrointestinal ulcer and was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: blood amylase increased, lipase increased, pancreatitis. Rifadin dosage: . During the same period patient was treated with CALCIPARINE (View Calciparine Review and Calciparine Label ), TARGOCID (View Targocid Review and Targocid Label ), INEXIUM (View Inexium Review and Inexium Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

6336497-X | Hepatitis Cholestatic
on Aug 26, 2009 Female patient from , 25 years of age, weighting 99.21 lb, was diagnosed with disseminated tuberculosis and was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic. Rifadin dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), AMIKLIN /00391001/ (View Amiklin /00391001/ Review and Amiklin /00391001/ Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ). Patient was hospitalized.

6301816-7 | Cholestasis
Patient was taking Rifadin (View Usage). Patient had the following side effects: cholestasis on Aug 03, 2009 from Additional patient health information: Female patient , 37 years of age, was diagnosed with disseminated tuberculosis and. Rifadin dosage: . During the same period patient was treated with IZILOX (View Izilox Review and Izilox Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), RIMIFON (View Rimifon Review and Rimifon Label ), ZECLAR (View Zeclar Review and Zeclar Label ), ANSATIPINE (View Ansatipine Review and Ansatipine Label ), SUSTIVA (View Sustiva Review and Sustiva Label ). Patient was hospitalized.

6301815-5 | Cholestasis, Cytolytic Hepatitis, Granulomatous Liver Disease, Hepatic Encephalopathy, Hepatitis Fulminant, Immune Reconstitution Syndrome, Insomnia, Jaundice, Lactic Acidosis
Adverse event was reported on Aug 03, 2009 by a Female patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with disseminated tuberculosis, insomnia and. Location: , 36 years of age, After Rifadin was administered, patient had the following side effects: cholestasis, cytolytic hepatitis, granulomatous liver disease, hepatic encephalopathy, hepatitis fulminant, immune reconstitution syndrome, insomnia, jaundice (What is jaundice?), lactic acidosis. During the same period patient was treated with PIRILENE (View Pirilene Review and Pirilene Label ), IMOVANE (View Imovane Review and Imovane Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), BACTRIM (View Bactrim Review and Bactrim Label ), RIMIFON (View Rimifon Review and Rimifon Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), TRUVADA (View Truvada Review and Truvada Label ), FUZEON (View Fuzeon Review and Fuzeon Label ).

6267099-1 | Cholestasis, Renal Failure
on Jul 09, 2009 Male patient from , 81 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, renal failure. Rifadin dosage: . During the same period patient was treated with ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), MOTILYOC (DOMPERIDONE) (View Motilyoc (domperidone) Review and Motilyoc (domperidone) Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), STILNOX /00914901/ (View Stilnox /00914901/ Review and Stilnox /00914901/ Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6262600-6 | Dyspnoea, Eosinophilia, Interstitial Lung Disease, Rash Pruritic
on Jul 07, 2009 Male patient from , 57 years of age, was diagnosed with atypical mycobacterial infection and was treated with Rifadin (View Usage). Patient had the following side effects: dyspnoea, eosinophilia, interstitial lung disease, rash pruritic. Rifadin dosage: . During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), DEXAMBUTOL (View Dexambutol Review and Dexambutol Label ), PIRILENE (View Pirilene Review and Pirilene Label ), ZECLAR (View Zeclar Review and Zeclar Label ). Patient was hospitalized.

6231285-7 | Dermatitis Exfoliative, Eosinophilia, Leukocytosis, Renal Failure Acute
Patient was taking Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: dermatitis exfoliative, eosinophilia, leukocytosis, renal failure acute on Jun 03, 2009 from Additional patient health information: Male patient , 71 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Rifadin dosage: . During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), FUCIDINE /00065702/ (View Fucidine /00065702/ Review and Fucidine /00065702/ Label ), SINEMET (View Sinemet Review and Sinemet Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), AMLOR (View Amlor Review and Amlor Label ), COKENZEN (View Cokenzen Review and Cokenzen Label ), HYPERIUM /00939801/ (View Hyperium /00939801/ Review and Hyperium /00939801/ Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

6231283-3 | Arthralgia
Adverse event was reported on Jun 08, 2009 by a Female patient taking Rifadin (View Usage) (Dosage: ) was diagnosed with pulmonary tuberculosis and. Location: , 66 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia. During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ADVAGRAF (TACROLIMUS) (View Advagraf (tacrolimus) Review and Advagraf (tacrolimus) Label ), IMUREL /00001501/ (View Imurel /00001501/ Review and Imurel /00001501/ Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6229314-X | Neutropenia
on Dec 16, 2008 Male patient from , 47 years of age, was diagnosed with brain abscess and was treated with Rifadin (View Usage). Patient had the following side effects: neutropenia. Rifadin dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PEFLACINE /00772701/ (View Peflacine /00772701/ Review and Peflacine /00772701/ Label ).

6229313-8 | Eosinophilia, Lichenoid Keratosis, Rash Maculo-papular, Toxic Skin Eruption
on Jun 12, 2008 Female patient from , 91 years of age, was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: eosinophilia, lichenoid keratosis, rash maculo-papular, toxic skin eruption. Rifadin dosage: . During the same period patient was treated with FUCIDINE /00065702/ (View Fucidine /00065702/ Review and Fucidine /00065702/ Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6223008-2 | Neutropenia
Patient was taking Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia on Dec 16, 2008 from Additional patient health information: Male patient , 47 years of age, was diagnosed with brain abscess and. Rifadin dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PEFLACINE /00772701/ (View Peflacine /00772701/ Review and Peflacine /00772701/ Label ).

6223007-0 | Eosinophilia, Lichenoid Keratosis, Rash Maculo-papular, Toxic Skin Eruption
Adverse event was reported on Jun 12, 2008 by a Female patient taking Rifadin (View Usage) (Dosage: ) . Location: , 91 years of age, Patient had the following side effects: eosinophilia, lichenoid keratosis, rash maculo-papular, toxic skin eruption. During the same period patient was treated with FUCIDINE /00065702/ (View Fucidine /00065702/ Review and Fucidine /00065702/ Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6219992-3 | Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholestasis, Jaundice
on Jun 02, 2009 Male patient from , 87 years of age, was treated with Rifadin (View Usage). After Rifadin was administered, patient had the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, jaundice (What is jaundice?). Rifadin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6216448-9 | Cholestasis, Hyperbilirubinaemia, Jaundice
on May 27, 2009 Female patient from , 89 years of age, was treated with Rifadin (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, hyperbilirubinaemia, jaundice (What is jaundice?). Rifadin dosage: . Patient was hospitalized.

6195991-5 | Aphthous Stomatitis, Asthenia, Blood Creatinine Increased, Cytolytic Hepatitis, Eosinophilia, Hypersensitivity, Hypotension, Pyrexia
Patient was taking Rifadin (View Usage). Patient had the following side effects: aphthous stomatitis, asthenia, blood creatinine increased, cytolytic hepatitis, eosinophilia, hypersensitivity, hypotension, pyrexia on May 14, 2009 from Additional patient health information: Male patient , 66 years of age, was diagnosed with osteitis and. Rifadin dosage: . During the same period patient was treated with OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), SOTALEX (View Sotalex Review and Sotalex Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), MICARDIS (View Micardis Review and Micardis Label ), LERCAN (View Lercan Review and Lercan Label ), PLAVIX (View Plavix Review and Plavix Label ), INEGY (View Inegy Review and Inegy Label ).